Zentalis Pharmaceuticals Inc. Stock Forecast
Zentalis Pharmaceuticals Inc. stock price ended at $12.57 on Tuesday, after losing 3.31%.
(Updated on Apr 23, 2024)
The Zentalis Pharmaceuticals Inc. stock price fell by -3.31% on the last day (Tuesday, 23rd Apr 2024) from $13.00 to $12.57. During the last trading day the stock fluctuated 7.08% from a day low at $12.57 to a day high of $13.46. The price has fallen in 7 of the last 10 days and is down by -20.14% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -67 thousand shares and in total, 379 thousand shares were bought and sold for approximately $4.77 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $12.45 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.29% during the next 3 months and, with a 90% probability hold a price between $14.23 and $19.17 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ZNTL Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 0.239%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zentalis Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.85 and $14.21. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Zentalis Pharmaceuticals Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $11.59 and $11.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zentalis Pharmaceuticals Inc. finds support just below today's level at $11.59. If this is broken, then the next support from accumulated volume will be at $11.50 and $10.83.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.89 between high and low, or 7.08%. For the last week, the stock has had daily average volatility of 5.39%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ZNTL) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Zentalis Pharmaceuticals Inc. to open at $12.87, and during the day (based on 14 day Average True Range), to move between $11.63 and $13.51, which gives a possible trading interval of +/-$0.94 (+/-7.49%) up or down from last closing price. If Zentalis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 14.97% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $13.41 (6.68%) than the support at $11.59 (7.80%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Zentalis Pharmaceuticals Inc. stock A Buy?
The Zentalis Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend, we believe Zentalis Pharmaceuticals Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -2.306 Sell Candidate Unchanged
Predicted Opening Price for Zentalis Pharmaceuticals Inc. of Wednesday, April 24, 2024
| Fair opening price April 24, 2024 | Current price |
|---|---|
| $12.87 ( 2.36%) | $12.57 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ZNTL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.76 | 9.44 % | |
| R2 | 13.42 | 6.74 % | ||
| R1 | 13.21 | 5.06 % | ||
| Current price: | 12.57 | |||
| Support | S1 | 12.53 | -0.345 % | |
| S2 | 12.32 | -2.02 % | ||
| S3 | 11.98 | -4.72 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 15.49 | 23.23 % | |
| R2 | 14.32 | 13.92 % | ||
| R1 | 13.41 | 6.68 % | ||
| Current price | 12.57 | |||
| Support | S1 | 11.59 | -7.80% | |
| S2 | 11.50 | -8.51% | ||
| S3 | 10.83 | -13.84% |
FAQ
Click here for our free guide on how to buy Zentalis Pharmaceuticals Inc. Stock.
